Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:25 PM
Ignite Modification Date:
2025-12-24 @ 7:25 PM
NCT ID:
NCT01065103
Eligibility Criteria:
Inclusion Criteria:
1. Any patient \>18 years of age with an acute STEMI eligible for primary PCI
2. Readily identifiable culprit vessel and at least one other (non-culprit) vessel of a least \>50% severity by traditional angiography
3. Deemed appropriate for a strategy of delayed revascularization of the NCV.
Exclusion Criteria:
1. Inability to provide informed consent
2. Cardiogenic shock or severe (Killip III) congestive heart failure
3. Hemodynamically significant ventricular arrhythmias
4. Severe recurrent clinically significant ischemia following successful PCI of the IRA
5. Thrombocytopenia (platelet count \<100,000)
6. Severe anemia (HgB \<100 g/L)
7. Major bleeding during hospitalization of the index STEMI
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT01065103
Study Brief:
Protocol Section:
NCT01065103